Ocu-Phrin Side Effects
Generic name: phenylephrine ophthalmic
Medically reviewed by Drugs.com. Last updated on Aug 15, 2023.
Note: This document provides detailed information about Ocu-Phrin Side Effects associated with phenylephrine ophthalmic. Some dosage forms listed on this page may not apply specifically to the brand name Ocu-Phrin.
Applies to phenylephrine ophthalmic: ophthalmic solution.
Common side effects of Ocu-Phrin
Some side effects of phenylephrine ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common with 2.5 or 10% solution
- burning or stinging of eyes
- headache or browache
- sensitivity of eyes to light
- watering of eyes
Less common side effects
- eye irritation not present before use of this medicine
Serious side effects of Ocu-Phrin
Along with its needed effects, phenylephrine ophthalmic (the active ingredient contained in Ocu-Phrin) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor as soon as possible if any of the following side effects occur while taking phenylephrine ophthalmic:
Symptoms of too much medicine being absorbed into the body
- Less common with 10% solution; rare with 2.5% or weaker solution- Dizziness
- fast, irregular, or pounding heartbeat
- increased sweating
- increase in blood pressure
- paleness
- trembling
For healthcare professionals
Applies to phenylephrine ophthalmic: intraocular solution, ophthalmic solution.
General adverse events
The more commonly reported adverse reactions have included eye pain and stinging on instillation, temporary blurred vision and photophobia.[Ref]
Cardiovascular
- Frequency not reported: Ventricular arrhythmias, myocardial infarction, hypertension, syncope, tachycardia, arrhythmia, palpitations, extrasystoles, reflex bradycardia, coronary artery spasm
There have been reports of serious cardiovascular reactions including ventricular arrhythmias and myocardial infarctions. Fatalities have been reported. Significant blood pressure elevations have been reported with recommended doses of 10% ophthalmic solution.
Ocular
- Frequency not reported: Eye pain and stinging on instillation, temporary blurred vision, photophobia, conjunctival allergy, reactive hyperemia, transient punctuate keratitis, lacrimation, corneal edema, pigmented aqueous floaters, rebound conjunctival vasoconstriction, rebound miosis, periorbital pallor
Periorbital pallor has been reported in preterm patients.
Hypersensitivity
- Frequency not reported: Hypersensitivity
Dermatologic
- Frequency not reported: Blanching of skin, increased perspiration
Nervous system
- Frequency not reported: Subarachnoid hemorrhage, headache, tremor or trembling, aneurisms
References
1. (2001) "Product Information. Neo-Synephrine (phenylephrine ophthalmic)." Sanofi Winthrop Pharmaceuticals
2. Cerner Multum, Inc. "UK Summary of Product Characteristics."
3. (2018) "Product Information. Phenylephrine Ophthalmic (phenylephrine ophthalmic)." Akorn Inc
More about Ocu-Phrin (phenylephrine ophthalmic)
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: mydriatics
- Breastfeeding
Patient resources
Other brands
Mydfrin, Prefrin, Altafrin, AK-Dilate, Neofrin
Professional resources
- Phenylephrine Hydrochloride (EENT) (Vasoconstrictor) monograph
- Phenylephrine Ophthalmic Solution (FDA)
Related treatment guides
Further information
Ocu-Phrin side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.